The effectiveness of botulinum toxin A injection for the treatment of secondary axillary bromhidrosis

Publication date: Available online 8 July 2017
Source:Journal of Plastic, Reconstructive & Aesthetic Surgery
Author(s): Jinguang He, Tao Wang, Jiasheng Dong
Surgical removal of apocrine glands is a valid treatment option for axillary bromhidrosis. However, malodor may recur after the operation. The value of botulinum toxin A (BTX-A) injection in the treatment of secondary axillary bromhidrosis was investigated in the present study. From July of 2012 to May of 2016, 53 patients with secondary axillary bromhidrosis were enrolled in our clinic. Various BTX-A injection strategies were applied depending on different types of previous surgery. None of the patients reported adverse side effects after the procedure. The duration of efficacy ranged from 1 month to 12 months, with the median value of 6 months. At the end of follow-up, a total of 48 patients ranked the satisfaction with BTX-A treatment as “very good” or “good.” For patients with secondary axillary bromhidrosis following various surgical modalities, the BTX-A treatment strategy we propose can achieve a lengthy duration of efficacy with a low risk of side-effects and should be considered to be a good and reliable option.



from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2uDszaX
via IFTTT